Background-Specimen labeling errors have long plagued the laboratory industry putting patients at risk of transfusion-related death, medication errors, misdiagnosis, and patient mismanagement. Many interventions have been implemented and deemed to be effective in reducing sample error rates. The objective of this review was to identify and evaluate the effectiveness of laboratory practices/ interventions to develop evidence based recommendations for the best laboratory practices to reduce labeling errors.
INTRODUCTION
Sample labeling errors have long plagued the laboratory industry putting patients at risk of transfusion-related death, medication errors, misdiagnosis, and patient mismanagement. It has been estimated over 160,000 adverse patient events occur each year in the U.S. because of patient or specimen identification errors involving the laboratory. 1 Eleven percent of all transfusion deaths occur as a result of the phlebotomist not properly identifying the patient or mislabeling the tube of blood. 2 Inadequately labeled samples account for 5.6-6.7% of all rejected samples. 3, 4 A 2009 Q-Probes study found the rate of tube mislabeling of blood bank samples to be 1.12 percent. 5 The use of barcoding systems for specimen labeling and point-of-care test barcoding was established by the Centers for Disease Control and Prevention (CDC) as a Best Practice in 2010 to reduce identification errors and improve the accuracy of patient specimen and laboratory testing identification in hospital settings. 6, 7 However, between 2007 and 2015 the incidence of wrong-blood-in-tube errors (WBIT) remained unchanged even though barcode scanner usage increased from eight percent to 38 percent during the same period. 8 A thorough literature review and establishment of Best Practices for the industry are necessary to protect patients from the threats of specimen labeling errors. The objective of this review is to identify and evaluate the effectiveness of existing interventions /practices to develop evidence based recommendations for the best laboratory practices to reduce sample labeling errors.
DESCRIPTION OF EVALUATED PRACTICES
In this review we evaluated the effectiveness of four laboratory practices to reduce the specimen labeling errors at the time of specimen collection, To address the applicability of the implementation of evaluated interventions to reduce specimen labeling errors, we also investigated whether the effectiveness of these practices vary according to the,
•
Type of setting/ population (e.g., emergency, in-patient, out-patient)
• Organization type (e.g., academic institution, private clinic)
The conceptual approach in Figure 1 illustrates the causal relationship of the laboratory interventions to the relevant intermediate outcomes, e.g., reduction in patient labeling errors and associated harm to patient health due to missed/ delayed diagnosis, unnecessary blood draws, wrong treatment and improved patient satisfaction by a decrease in treatment delay, hospital stay, and related costs. Ultimately, these interventions may lead to decrease in overall morbidity and mortality and decrease in healthcare costs at organizational level.
Following PICO elements were considered for this review:
Population-General patients attending all types of healthcare settings who require specimen collection for diagnostic laboratory testing. Mismatched labels-Patient information on the label does not meet with the accompanying requisition form or patient information on specimen label does not match with the patient's wrist band Incomplete, illegible or unlabeled specimen label-A specimen with a label that lists only partial information of required unique patient identifier; a specimen without a label or without any patient identifiers on the label; and finally specimen label that had illegible patient identifiers that could be read electronically or manually respectively.
Intervention-Following

Inclusion /Exclusion Criteria for Evidence to be Included in this Review
Exclusion Criteria: To be included in this review the study had to
• evaluate the effectiveness of at least one of the interventions/ practices of interest to reduce specimen labeling error;
• report at least one of the outcomes of interest (listed above) after the intervention implementation;
• be primary research published in an English-language journal, or available as a dissertation or a technical or government report;
• employ a study design that compared outcomes of interest with and without the new practice implementation to reduce specimen mislabeling e.g., pre-and postintervention data, concurrent comparison data such as RCTs. In addition, this review included labeling errors associated with all types of patient specimens collected from the patients for laboratory diagnostic testing (e.g., blood, urine, CSF, sputum).
Exclusion Criteria:
The studies on the effectiveness of barcoding practices for reducing patient specimen and laboratory testing identification errors were excluded from the 'Implementation of New Technology' category as these practices are already evaluated in one of the previous LMBP reviews. 7 
Acquire (A-2): Search for Evidence
Published evidence was searched between the time periods of 1990 to September 2015 using the following databases: Medline OVID (R), Embase OVID, CINAHL EbscoHost, Cochrane Library Database, Dissertation Abstracts, and PubMed to identify studies relevant to evaluations of interventions to reduce specimen mislabeling. Search details are available at Supplemental Appendix C. In addition, the systematic review team retrieved evidence from other informal sources such as hand searches including relevant references from all retrieved articles and additional studies identified by subject matter experts on the e-SBI systematic review team were incorporated into the review. We also received relevant unpublished data from the researchers, laboratories, and institutions in the field through personal requests and LMBP™ website but none of the unpublished data qualified to be included in this review. A total of 10,854 relevant records (both published and unpublished) were retrieved as a result of formal and informal literature searches. (Figure 2 )
Appraise (A-3): Screening, Data abstraction and Quality scoring of Individual Studies
Retrieved evidence was screened at different levels, e.g., title screening and abstract screening to identify studies meeting the inclusion criteria. The data was abstracted from each study that met the inclusion criteria by 2 reviewers using the Standardized LMBP™ abstraction methods and abstraction form. Any discrepancies among the reviewers were reconciled by consensus. Based on the abstracted data, each study was rated using a 10 point scale for study quality as good (8-10 score), fair (5-7 score), or poor (≤4 score). Details for the LMBP quality scoring process can be found elsewhere. 10 Studies with good and fair quality of execution were included in this review analysis. Supplemental Appendix D describes the Evidence Summary Tables containing detail information and quality ratings for each study.
Analyze (A-4): Summarization of results and strength of the Effect Magnitude
Effect estimates for each practice effectiveness were calculated as relative percentage point change (pct pt) where the studies reported the percent change in specimen labeling errors due to the intervention implementation. For each study, the effect estimates were calculated separately using the last available data point.
Where the Intervention Pre and Intervention Post represent the percent of labeling errors before and after the intervention implementation respectively.
The effect size strength rating for each individual study was based on the range of percentage change in labeling errors due to the intervention, the reduction in labeling errors between 0% to ≤ 40% was considered 'minimal' magnitude of effect; any decrease in labeling errors between >40% to ≤ 75% was considered 'moderate' magnitude and finally any decrease in labeling errors > 75% was considered 'substantial' magnitude of effect.
LMBP criteria were used to make conclusions on the overall strength of evidence on effectiveness which is based on the total body of evidence by taking into account the number of studies included in the evidence, quality of available evidence, consistency of results, magnitude of effect estimates, and applicability considerations. More details about these criteria can be found elsewhere. 6 
RESULTS
From the broader search for evidence, a total of 10,854 references were retrieved. After removing 167 duplicates and 10,567 off the topic, 66 were considered for full abstraction. After the full abstraction and quality scoring, eleven studies were qualified to be included in the systematic review. (Figure 2 ) Majority of the studies were conducted in USA [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , one in India 21 and one in Spain. 22
Practice 1: Improved Communication and Collaboration between Laboratory and Healthcare Professionals: Formation of Multidisciplinary Teams
Seven studies 11, [15] [16] [17] [18] [19] [20] were identified to be included in the analyses to investigate the effectiveness of interventions that were developed and implemented due to the improved communication and collaboration between clinical staff and laboratory personnel. Three 18-20 studies were of 'good' quality and four studies 11, [15] [16] [17] were of 'fair' quality. All identified interventions for this category comprised of formation of multidisciplinary teams including the representatives from diverse disciplines (e.g., testing laboratory personnel, clinicians, nurses or other healthcare professionals). The teams met on regular basis to develop collaborative approaches according to the organizational needs that were acceptable and sustainable to staff in order to reduce specimen identification errors. The interventions were targeted to the general population in five studies [15] [16] [17] [18] 20 , children and adults in one study, 19 and in one study the target population was newborn children. 11 The total evidence was derived from varied types of healthcare settings, i.e., three studies [15] [16] [17] were conducted in entire facilities including different settings such as inpatient, ambulatory, surgical services areas, emergency department, ICU, general care unit, one study 19 in inpatient setting, one 20 in surgical unit, one 18 in dermatology unit, and one 11 in pediatric department.
Four studies 15, [18] [19] [20] measured the effect of standardized specimen labeling policies developed as a result of multidisciplinary approach that required inclusion of specific patient identifiers in specimen labeling (e.g., patient full legal name, DOB, Date and time of collection, initials of person collecting the specimen) and also educated staff about those standardized policies. Three studies [18] [19] [20] implemented policies that required to print specimen labels at the time of specimen labeling process and use of one sheet for blood and other bodily fluid specimens from the same patient.
The overall findings from the combined data from seven studies 11, [15] [16] [17] [18] [19] [20] found that the interventions developed as a result of improved communication and collaboration between the laboratory and clinical staff resulted in substantial decrease in specimen labeling errors (Median relative percent change in labeling errors: −75.86; IQI: −84.77, −58.00). (Figure 3) .
Results from all studies were statistically significant but for one study 17 due to the limited information available to calculate the significance of results. The strength of the effect size was considered 'substantial' from four studies 11, 15, 17, 19 'moderate' from two studies, 16, 20 and 'minimal' for one study 18 . Overall data showed that improved communication and collaborative efforts by the clinical and laboratory staff (e.g., development of standardized policies and practices for specimen labeling and organizational workflow chart to determine strategies to check for any scope of errors, establishment of processes to check specimen slips for missing collection dates) resulted in significant decrease in the rate of specimen identification errors.
In addition, the results from the sub-analyses performed for four studies 15, [18] [19] [20] showed a 'moderate' decline in specimen labeling errors after the institution of the standardized specimen labeling policy, i.e., inclusion of unique patient identifiers on the specimen labeling. (Median relative percent decrease in specimen labeling errors: −72.45; IQI: −83.25, −46.50). The results from all these studies were statistically significant and were consistently in a favorable direction. (Figure 4 ).
Conclusions-Applying the LMBP™ criteria, the overall strength of evidence from seven studies 11, 15-20 is considered 'sufficient' to recommend that the improved communication and collaboration between laboratory and healthcare professionals by forming multidisciplinary teams is effective to decrease the specimen identification errors. (Table 1) Based on sub-group analysis, there was sufficient evidence of 'moderate' strength' (based on four studies) 15, [18] [19] [20] to recommend that the implementation standardized policies that require specific patient identifiers on specimen label developed by collaborative efforts between laboratory and healthcare staff are effective in decreasing specimen labeling in healthcare settings. (Table 2 )
Practice 2: Education and Training
Two studies 13, 21 were identified that evaluated the effectiveness of education and training interventions to decrease the specimen labeling errors. One study 21 was good quality and one 13 was of fair quality. Results from one study 21 showed substantial reduction in patients with wrong identification due to the labeling errors. (Relative percent change: −90.89; IQI: −97.86, −61.14) after introducing training and education sessions for medical, nursing, and laboratory staff as part of the continuous medical education. Another study 13 showed minimal decrease in the specimen labeling after the nursing in-service education over the period of six months along with the provision of 24-hour phlebotomy services at the facility. Conclusions-Both included studies showed a consistent decrease in sampling errors, however due to the small number of studies, according to the LMBP rules, 6 evidence is considered 'insufficient' to determine if education and training interventions are effective in reducing patient misidentification due to the labeling errors. (Table 3 )
Practice 3: Audit and Feedback
Three studies 12, 13, 22 were included in the analyses to investigate the effectiveness of audit and feedback interventions. One study 22 was of 'good' quality and two 12, 13 studies were of 'fair' quality of execution. Two studies 12, 13 were conducted in the USA and one study in Spain. 22 The interventions in the included studies involved reporting or feedback of specimen mislabeling data from the laboratories to the management and the staff responsible for specimen collection and labeling on a regular basis. The combined results from three studies showed that after the intervention implementation there was a significant decrease in labeling errors (Overall decrease in median relative percent change in labeling errors: −58.0; IQI: −74.77, −30.08). Results from the two studies 13, 22 were statistically significant and from one study 12 were not statistically significant. (Figure 6 ) The effect size from two studies 12, 13 was of 'moderate' strength and from one study 22 was of 'minimal' strength. (Table 4) In laboratory medicine, correct linking of the specimen to the patient from whom it was collected is identified as an essential and fundamental objective for improving patient health and safety as it impacts on all aspects of patient care including correct diagnosis and right treatment. In 2013, Joint Commission identified accurate specimen/ patient identification as first of the National Patient Safety Goals, and this continues to be an accredited requirement . 23 The World Health Organization (WHO) considers identification a priority area for improving patient safety, recommends for staff education and training to ensure correct specimen/patient identification among all healthcare organizations. 24 Various approaches have been proved to be effective to improve specimen labeling errors when implemented among different facilities within a health-care system. Evidence showed that education and training programs for the staff responsible for specimen collection and labeling 22, 25, 26 and audit/continuous monitoring and reporting of specimen labeling 27 have been proved to reduce specimen/patient identification error. [27] [28] [29] The findings from our review appear to be similar to a recent systematic review that addressed the errors related to the wrong blood in tube (WBIT) and investigated what interventions (single or multiple) were successful in reducing WBIT. This review found that the interventions including standardized labeling policies, staff education, weekly feedback, and electronic transfusion systems were likely to be more effective when implemented in combination than when implemented individually. 30 However, most of the evidence came from the studies that implemented multiple practices at the same time and did not make an attempt to investigate the weighing of effectiveness of individual practice in relation to the other.
In this review we were able to measure the effectiveness of four individual practices to reduce the specimen labeling errors at the time of specimen collection.
CONSIDERATIONS FOR IMPLEMENTATION
Lack of knowledge and training of non-laboratory staff (e.g., doctors and nurses) regarding specimen collection procedures like phlebotomy may contribute to pre analytical errors including specimen mislabeling. Educational and training interventions targeting nonlaboratory staff can be more effective to improve specimen mislabeling. 13, 19, 31 Other factors contributing to labeling errors are identified as lack of compliance by the staff to the specimen labeling SOPs majority of the times due to the short cuts and workarounds 32 , furthermore staff turnover is a major issue in lab and nursing. 33 To mitigate these barriers incorporating staff training sessions into their orientation as well as routine continuing ongoing professional development sessions may prove to be more effective vs. one time training. Annual competency checks for new as well as existing employee(s) is required. Finally it is also suggested that patient involvement can play an important role to improve their own identification. Therefore, interventions that encourage patient and family involvement to verify and confirm patient information should not be undervalued in order to reduce patient identification errors. 24 
ECONOMIC EVALUATION
No eligible economic evaluations were identified for analysis of cost-effectiveness.
POTENTIAL HARMS
Some of the interventions to reduce specimen labeling errors may have unintended disadvantages. Interventions may result in increased cost of operations due to implementation and maintenance of staff education and training. There can be additional cost associated with acquiring technical solutions and the training of the staff about the use of new technology. In addition, regular educational/trainings sessions may result in increase in staff workload and time spent away from the patients. Health care providers perceive that by repeated verification of patient identity may compromise their relationship with the patients.
STUDY LIMITATIONS AND FUTURE RESEARCH NEEDS
Due to the limited available evidence, no recommendations-'for or against', the effectiveness the effectiveness of three evaluated practices could be made, i.e. interventions including education and training, 13, 21 audit and feedback 12, 13, 22 and implementation of new technology. More research is needed to evaluate these interventions to reduce specimen labeling errors.
Study design limitations regarding the entire evidence driven from before-and-after study design studies. Because of the uncontrolled nature of this design, there may have been unmeasured factors that changed between study periods that account for or influence the study results. Future studies of stronger research designs (e.g., randomized control trials) would be valuable to clarify effectiveness of interventions to reduce patient misidentification due to the labeling errors.
In this review, implementation of policies and strategies for specimen labeling developed as a result of improved communication and collaboration between the laboratory, management, and clinical staff remained effective for longer period (up to 3 years) of time. However, for other evaluated practices, i.e., staff education, audit and feedback interventions the follow-up period to report the results varied from 6 months to 1 year, 12, 13, 21, 22 future research studies need to be conducted over a prolonged period required to examine the sustainability of the effects of these interventions for longer periods of time.
Large discrepancies in errors definitions, terminology, and error categorization strategies used in existing literature made it difficult to compare the studies. For example, the terms 'laboratory identification error', 'specimen identification error', 'patient identification error', 'identification error', 'mislabeled specimen', 'unlabeled specimen' have been interchangeably used for specimen labeling. Furthermore, use of variety of metrics/ measures for result reporting, such as percent change, change in error rate, error counts etc. made it challenging and difficult for synthesizing and summarizing findings from the total evidence. For future research it is warranted to use standardize term(s), definition(s) and error detection methods and measures for result reporting in establishing future quality control studies to allow better analysis and better result interpretation.
In the majority of the existing literature, across the healthcare settings combination of interventions were implemented at the same time, e.g., staff training and education, labeling policies and processes to reduce the errors. It was difficult to disentangle what specific component attributed to the intervention effectiveness (e.g., do policy components or education components contribute more to intervention effectiveness; what are the central "active ingredients" in complex interventions). Providing more description information on how different best practices were implemented as an intervention to reduce errors might also help organizations replicate successes. The unpublished data that was retrieved from the laboratories was mostly trend data that did not qualify to be included in the final analyses, e.g., did not provide any comparison data to calculate the effect estimates. In routine, clinical laboratories study patient safety and quality improvement interventions, it is desired to design future quality improvement studies in such a way that the data driven from these studies can be utilized to demonstrate intervention effectiveness.
Finally, research showed that the incidence of specimen labeling errors vary according to the type of healthcare setting. For example the risk of these events is higher in the emergency departments due to rapid patient turnover, more interruptions to the medical staff in ED, 32 patients arrive unexpectedly who maybe unconscious or with no identification when compared to in patient setting where the patients are admitted for days for their treatment. 33 The findings from this review may not be generalizable across different type of healthcare settings due to limited data availability to investigate whether the recommended practices are equally effective in all types of settings (e.g., ED, pediatrics).
In summary, humans tend to cause errors and multiple corrective measures exist that focus on human factor improvement but the errors related to specimen labeling and patient identification continue to happen. Due to the potential adverse consequences on patient safety associated with mislabeled laboratory specimens, each and every specimen labeling error should be treated very seriously. Based on the findings from this review, multifaceted and multidisciplinary improvement approaches such as improved communication and collaboration between laboratory and healthcare professionals to develop and implement stringent and standardized specimen labeling policies and procedures can increase the patient safety by significantly reducing the incidence of specimen labeling errors at healthcare settings.
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